The FDA has approved Kerendia® (finerenone) to reduce the risk of cardiovascular death, hospitalization for HF, and urgent HF visits.

Nuwellis terminated its REVERSE‑HF randomized trial comparing ultrafiltration with IV loop diuretics in hospitalized heart ...